|
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.
|
1R01CA228512-01
|
$504,230
|
$504,230
|
GIANNAKAKOU, PARASKEVI
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
$25,171
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
H. Pylori Relationship to Digestive Diseases and Cancer
|
2R01CA077955-22
|
$463,142
|
$463,142
|
PEEK, RICHARD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
H. pylori-Induced Inflammation and gastric cancer
|
5P01CA116087-11
|
$1,384,046
|
$1,079,556
|
PEEK, RICHARD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA068485-23S1
|
$118,377
|
$10,654
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA068485-23S2
|
$249,999
|
$22,500
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA068485-23S3
|
$199,229
|
$17,931
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA068485-23S4
|
$199,943
|
$17,995
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA068485-23S5
|
$120,443
|
$10,840
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
5P30CA068485-23
|
$5,853,094
|
$526,778
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Etiological Studies of Gastric Carcinoma
|
5P01CA028842-33
|
$1,038,693
|
$1,038,693
|
WILSON, KEITH
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Targeted chemoprevention of gastric carcinogenesis in high risk populations
|
5R01CA190612-06
|
$568,634
|
$568,634
|
WILSON, KEITH
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-05
|
$644,932
|
$8,062
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-05
|
$1,267,600
|
$15,845
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
NCI NCTN- Network Lead Academic Participating Site: USC
|
5U10CA180830-05
|
$523,827
|
$26,191
|
LENZ, HEINZ JOSEF
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
NCI NCTN-Network Lead Academic Site at UPCI
|
5U10CA180844-05
|
$898,424
|
$22,461
|
BRUFSKY, ADAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
The Role of Aurora Kinase in Upper Gastrointestinal Adenocarcinomas
|
5R01CA131225-12
|
$345,375
|
$172,688
|
EL-RIFAI, WAEL
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Extent and Significance of Bacterial DNA Integrations in the Human Cancer Genome
|
5R01CA206188-04
|
$1
|
$1
|
HOTOPP, JULIE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
NCI National Clinical Trials Network-Network Lead Academic Participating Sites
|
5U10CA180836-05
|
$634,699
|
$15,867
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
Cancer Center Support Grant
|
2P30CA014599-43
|
$4,593,451
|
$45,935
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Cancer Center Support Grant
|
3P30CA014599-43S1
|
$60,000
|
$600
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Cancer Center Support Grant
|
3P30CA014599-43S2
|
$57,651
|
$577
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Manipulation of Tumor Specific Immunity
|
5R01CA022677-37
|
$288,325
|
$144,163
|
SCHREIBER, HANS
|
UNIVERSITY OF CHICAGO
|
|
Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers
|
5R35CA197694-03
|
$892,951
|
$294,674
|
TLSTY, THEA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-32S1
|
$92,737
|
$927
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-32S2
|
$45,316
|
$453
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-32S3
|
$116,250
|
$1,163
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-32S4
|
$58,328
|
$583
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-32S5
|
$158,571
|
$1,586
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-32S6
|
$63,682
|
$637
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
5P30CA023100-32
|
$4,049,944
|
$40,499
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
MyD88-dependent mechanisms of Helicobacter pylori-induced gastric cancer progression
|
5R21CA210227-02
|
$168,563
|
$168,563
|
OBONYO, MARYGORRET
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Genetic studies of homologous recombination deficiency in hispanic gastric cancer
|
1R01CA223978-01
|
$617,977
|
$617,977
|
CARVAJAL CARMONA, LUIS
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-05
|
$623,007
|
$15,575
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant P30
|
3P30CA093373-16S1
|
$250,000
|
$7,500
|
LARA, PRIMO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant P30
|
3P30CA093373-16S2
|
$89,478
|
$2,684
|
LARA, PRIMO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant P30
|
3P30CA093373-16S3
|
$59,999
|
$1,800
|
LARA, PRIMO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant P30
|
3P30CA093373-16S4
|
$200,000
|
$6,000
|
LARA, PRIMO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant P30
|
3P30CA093373-16S5
|
$125,000
|
$3,750
|
LARA, PRIMO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Development of a research infrastructure for understanding and addressing multiple melanoma disparities.
|
3P30CA093373-16S6
|
$235,500
|
$7,065
|
LARA, PRIMO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant P30
|
5P30CA093373-16
|
$2,882,980
|
$86,489
|
LARA, PRIMO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
|
1U54CA233306-01
|
$6,160,778
|
$924,117
|
PAN, CHONG-XIAN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
NCTN Deep South Research Consortium
|
5U10CA180855-05
|
$436,712
|
$5,459
|
LEATH, CHARLES
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Breaking the paradigm: RhoA as a tumor suppressor in cancer
|
5F31CA216965-02
|
$30,558
|
$30,558
|
BLAKE, DEVON
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
NCTN Lead Academic Participating Sites Application
|
5U10CA180838-05
|
$623,046
|
$31,152
|
CAREY, LISA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Health Disparities Training Program
|
5T32CA128582-10
|
$175,581
|
$17,558
|
ENG, EUGENIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Stanford Cancer Institute
|
3P30CA124435-11S1
|
$248,520
|
$2,485
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
$1,715
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
$33,345
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms
|
5U01CA217851-02
|
$946,251
|
$312,263
|
KUO, CALVIN
|
STANFORD UNIVERSITY
|
Total relevant funding to Stomach for this search: $14,206,953
|